Today's surprising #340B data point: @Merck $MRK disclosed that one-third (!) of #Keytruda sales come from #340B covered entities https://t.co/d0Kog5vMpr

More evidence that this program is an unexpectedly large share of the pharma market. Discounts are likely &gt;60%.